MEEDER ASSET MANAGEMENT INC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 134 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$77,000
+1440.0%
10,770
+206.1%
0.01%
Q1 2020$5,000
+66.7%
3,519
+157.0%
0.00%
Q4 2019$3,000
+50.0%
1,369
+238.9%
0.00%
Q3 2019$2,000
-85.7%
404
-79.7%
0.00%
-100.0%
Q2 2019$14,000
-63.2%
1,990
-29.9%
0.00%
-66.7%
Q1 2019$38,000
+660.0%
2,839
+307.3%
0.00%
Q4 2018$5,0006970.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 2,254,502$20,741,00014.54%
Versant Venture Management, LLC 1,048,601$9,647,127,00010.15%
Abingworth LLP 1,147,077$10,553,0007.65%
Omega Fund Management, LLC 551,477$5,074,0003.67%
Opaleye Management Inc. 665,000$6,118,0001.96%
DAFNA Capital Management LLC 361,164$3,323,0001.79%
Boxer Capital, LLC 1,012,986$9,319,0001.70%
Foresite Capital Management III, LLC 600,000$5,520,0001.55%
NEXTHERA CAPITAL LP 536,568$4,936,0000.91%
Perceptive Advisors 2,685,882$24,710,0000.82%
View complete list of CYMABAY THERAPEUTICS INC shareholders